½ÃÀ庸°í¼­
»óǰÄÚµå
1586176

¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Cell Culture Media Market by Product Type (Chemically Defined Media, Classical Media, Lysogeny Broth), Application (Biological Drug Discovery, Biopharmaceuticals, Cancer Research), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀº 2023³â¿¡ 14¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 16¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 13.53%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 34¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼Æ÷ ¹è¾ç ¹èÁö´Â ¼¼Æ÷ÀÇ ½ÃÇè°ü ³» Áõ½Ä ¹× À¯Áö¿¡ Áß¿äÇÑ ¿µ¾ç ¿ë¾×À¸·Î ÀÛ¿ëÇÏ¸ç ¿¬±¸, »ý¸í°øÇÐ ¹× Á¦¾à ÀÀ¿ë ºÐ¾ß¿¡¼­ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¹ÙÀÌ¿À ÀǾàǰ, Áٱ⼼Æ÷ ¿¬±¸, ¼¼Æ÷ ±â¹Ý ºÐ¼®¹ý °³¹ß¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±× Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖÀ¸¸ç, ½Å¾à °³¹ß, Àç»ýÀÇÇÐ, ¾Ï ¿¬±¸ µî ´Ù¾çÇÑ ºÐ¾ß¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ë ºÐ¾ß¿¡´Â Çаè, ¿¬±¸¼Ò, »ý¸í°øÇÐ ¹× Á¦¾àȸ»ç µîÀÌ Æ÷ÇԵǾî ÀÖ¾î ¾÷°è Àü¹Ý¿¡ °ÉÃÄ Æø³ÐÀº ¿¬°ü¼ºÀ» º¸ÀåÇÕ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, À¯Àü°øÇÐÀÇ ¹ßÀü, ¹ÙÀÌ¿À Á¦Á¶ ±â¼úÀÇ Çõ½Å µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¹«Ç÷û, È­ÇÐÀûÀ¸·Î Á¤ÀÇµÈ ¸ÂÃãÇü ¹èÁö Á¦ÇüÀ¸·ÎÀÇ ÀüȯÀº ƯÁ¤ ¿¬±¸ ¹× »ý»ê ¿ä±¸ »çÇ×À» ÃæÁ·½Ã۱â À§ÇÑ ½ÃÀåÀÇ ÀûÀÀÀ» ¹Ý¿µÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 14¾ï 2,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 16¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 34¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 13.53%

ÀáÀçÀûÀÎ ¼ºÀå ±âȸ´Â ¹Ìµð¾î ó¹æÀ» ÃÖÀûÈ­Çϱâ À§ÇÑ ÀΰøÁö´ÉÀÇ ÅëÇÕ°ú È®Àå °¡´ÉÇϰí Áö¼Ó °¡´ÉÇÑ »ý»êÀ» À§ÇÑ ÇÁ·Î¼¼½º ÀÚµ¿È­¿¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀå ÁøÃâ°ú ÇÐ°è ¹× ¿¬±¸ ±â°ü°úÀÇ Çù·ÂÀº Çõ½ÅÀûÀÎ ¹Ìµð¾î ¼Ö·ç¼ÇÀÇ º¸±Þ°ú Àû¿ëÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÏÁö¸¸, ¿ø·áºñ »ó½Â, ¾ö°ÝÇÑ ±ÔÁ¦, ¹èÁö ±¸¼ºÀÇ Àϰü¼º À¯ÁöÀÇ º¹À⼺ µîÀÇ °úÁ¦µµ ¿©ÀüÈ÷ ³²¾ÆÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿¹° À¯·¡ ¼ººÐ »ç¿ë¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á Áõ°¡·Î ÀÎÇØ Á¦ÇüÈ­ °øÁ¤ÀÇ Áö¼ÓÀûÀÎ °³¼±ÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.

»ç¾÷ ¼ºÀåÀ» ±Ø´ëÈ­Çϱâ À§ÇØ ±â¼ú Çõ½ÅÀº ȯ°æÀûÀ¸·Î Áö¼Ó °¡´ÉÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¹èÁö °³¹ß, ÷´Ü ¼¼Æ÷ ¸ðµ¨À» Áö¿øÇÏ´Â Á¦Çü °­È­, Àå±â Ĩ°ú °°Àº ½ÅÈï ºÐ¾ßÀÇ ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¾î¾ß ÇÕ´Ï´Ù. ½ÃÀå ¼ö¿ä¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ´Â À¯¸ÁÇÑ ºÐ¾ßÀÔ´Ï´Ù. ½ÃÀåÀÇ ¼øÈ¯Àû Ư¼ºÀ» ÀÌÇØÇÏ¸é ±â¼ú ¹ßÀü°ú ±ÔÁ¦ º¯È­¿¡ ÀûÀÀÇÒ ¼ö ÀÖ´Â ¹Îø¼ºÀÌ Áß¿äÇÏ´Ù´Â °ÍÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ °æ·Î¸¦ Ȱ¿ëÇÏ¸é ±â¾÷Àº ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÌ ºÐ¾ß¿¡¼­ °æÀï·ÂÀ» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼Æ÷¹è¾ç ±â¹Ý ¹é½Å¿¡ ´ëÇÑ ÅõÀÚ È®´ë
    • ´ÜŬ·Ð Ç×ü¿¡ ´ëÇÑ ¼ö¿ä¿Í ¼¼Æ÷ ±â¹Ý ¿¬±¸ ÇÁ·ÎÁ§Æ®¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡
    • ÀÏȸ¿ë ±â¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº ¼¼Æ÷»ý¹°ÇÐ ¿¬±¸ ºñ¿ë
  • ½ÃÀå ±âȸ
    • 3D ¼¼Æ÷ ¹è¾ç°ú °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • À¯Çິ°ú Àü¿°º´¿¡ ´ëÇÑ Á¶¼ÓÇÑ ´ëó ÇÊ¿ä
  • ½ÃÀå °úÁ¦
    • ÀÓ»ó ½ÇÇè½ÇÀÇ ¼÷·ÃµÈ Àü¹® Áö½Ä ºÎÁ·

Portre's Five Forces: ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå¿¡¼­ÀÇ °æÀï»óȲ ÆÄ¾Ç

¼¼Æ÷ ¹è¾ç ¹èÁö ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå¿¡¼­ÀÇ ¼º°ø Àü·« ºÐ¼® ¹× Ãßõ ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå ¼º°øÀÇ ±æÀ» ±×¸®´Ù.

¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå : Á¦Ç° À¯Çüº°

  • È­ÇÐÀûÀ¸·Î Á¤ÀÇµÈ ¹èÁö
  • °íÀü ¹Ìµð¾î
  • ¿ë¿ø¼º ¹è¾ç¾×
  • ¹«Ç÷û ¹èÁö
  • Àü¹® ¹Ìµð¾î
  • Áٱ⼼Æ÷ ¹Ìµð¾î

Á¦7Àå ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå : ¿ëµµº°

  • »ý¹°ÇÐÀû ÀǾàǰ ¹ß°ß
  • ¹ÙÀÌ¿ÀÀǾàǰ
  • ¾Ï ¿¬±¸
  • Áٱ⼼Æ÷ ±â¼ú
  • Á¶Á÷°øÇÐ

Á¦8Àå ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Çмú±â°ü
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö »ê¾÷
  • ¿¬±¸°³¹ß ¿¬±¸¼Ò

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Corning Incorporated
  • Eppendorf SE
  • Fujifilm Irvine Scientific
  • GE Healthcare Life Sciences
  • HiMedia Laboratories Pvt., Ltd
  • Invivogen
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec
  • PromoCell GmbH
  • Sartorius CellGenix GmbH
  • Thermo Fisher Scientific Inc.
  • Vitro Diagnostics, Inc.
LSH.

The Cell Culture Media Market was valued at USD 1.42 billion in 2023, expected to reach USD 1.61 billion in 2024, and is projected to grow at a CAGR of 13.53%, to USD 3.46 billion by 2030.

Cell culture media serves as a crucial nutrient solution for the in vitro growth and maintenance of cells and is pivotal in research, biotechnology, and pharmaceutical applications. Its necessity is underscored by the increasing demand for biopharmaceuticals, stem cell research, and development of cell-based assays, with applications spanning drug discovery, regenerative medicine, and cancer research. End-use segments involve academic institutions, research laboratories, and biotechnology and pharmaceutical companies, ensuring broad industry relevance. Key growth influencers include the rising emphasis on personalized medicine, advancements in genetic engineering, and innovations in biomanufacturing technologies. The shift towards serum-free, chemically-defined, and customized media formulations reflects market adaptation to meet specific research and production requirements.

KEY MARKET STATISTICS
Base Year [2023] USD 1.42 billion
Estimated Year [2024] USD 1.61 billion
Forecast Year [2030] USD 3.46 billion
CAGR (%) 13.53%

Potential growth opportunities lie in the integration of artificial intelligence to optimize media formulation and process automation for scalable and sustainable production. Furthermore, the expansion into emerging markets, as well as collaborations with academic and research institutes, could enhance the reach and application of innovative media solutions. However, challenges persist, including high costs of raw materials, stringent regulatory landscapes, and the complexity of maintaining consistency in media composition. Additionally, the rise of ethical concerns regarding the use of animal-derived components imposes hurdles, necessitating ongoing refinement in formulation processes.

To maximize business growth, innovation should focus on developing environmentally sustainable and cost-effective media, enhancing formulations to support advanced cellular models, and addressing the needs of emerging sectors like organ-on-a-chip. Research in optimizing media for 3D cultures and organoid development presents a promising area to capture market demand. Understanding the cyclical nature of the market emphasizes the importance of agility in adapting to technological advancements and regulatory changes. By leveraging these innovative pathways, businesses can position themselves competitively within this rapidly evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Culture Media Market

The Cell Culture Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing investment in cell culture-based vaccines
    • Demand for monoclonal antibodies and increased funding for cell-based research projects
    • Growing preference for single-use technologies
  • Market Restraints
    • High cost of cell biology research
  • Market Opportunities
    • Growing demand for 3D cell culture & personalized medicine
    • Need to immediately combat pandemics and communicable diseases
  • Market Challenges
    • Shortage of trained expertise in clinical laboratories

Porter's Five Forces: A Strategic Tool for Navigating the Cell Culture Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Culture Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Culture Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Culture Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Culture Media Market

A detailed market share analysis in the Cell Culture Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Culture Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Culture Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Culture Media Market

A strategic analysis of the Cell Culture Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Media Market, highlighting leading vendors and their innovative profiles. These include Avantor, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Eppendorf SE, Fujifilm Irvine Scientific, GE Healthcare Life Sciences, HiMedia Laboratories Pvt., Ltd, Invivogen, Lonza Group AG, Merck KGaA, Miltenyi Biotec, PromoCell GmbH, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc., and Vitro Diagnostics, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Chemically Defined Media, Classical Media, Lysogeny Broth, Serum-Free Media, Specialty Media, and Stem Cell Media.
  • Based on Application, market is studied across Biological Drug Discovery, Biopharmaceuticals, Cancer Research, Stem Cell Technologies, and Tissue Engineering.
  • Based on End-User, market is studied across Academic Institute, Biotechnology Industry, and Research & Development Laboratory.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing investment in cell culture-based vaccines
      • 5.1.1.2. Demand for monoclonal antibodies and increased funding for cell-based research projects
      • 5.1.1.3. Growing preference for single-use technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cell biology research
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for 3D cell culture & personalized medicine
      • 5.1.3.2. Need to immediately combat pandemics and communicable diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained expertise in clinical laboratories
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Culture Media Market, by Product Type

  • 6.1. Introduction
  • 6.2. Chemically Defined Media
  • 6.3. Classical Media
  • 6.4. Lysogeny Broth
  • 6.5. Serum-Free Media
  • 6.6. Specialty Media
  • 6.7. Stem Cell Media

7. Cell Culture Media Market, by Application

  • 7.1. Introduction
  • 7.2. Biological Drug Discovery
  • 7.3. Biopharmaceuticals
  • 7.4. Cancer Research
  • 7.5. Stem Cell Technologies
  • 7.6. Tissue Engineering

8. Cell Culture Media Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Institute
  • 8.3. Biotechnology Industry
  • 8.4. Research & Development Laboratory

9. Americas Cell Culture Media Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Culture Media Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Media Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Avantor, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories Inc.
  • 4. Corning Incorporated
  • 5. Eppendorf SE
  • 6. Fujifilm Irvine Scientific
  • 7. GE Healthcare Life Sciences
  • 8. HiMedia Laboratories Pvt., Ltd
  • 9. Invivogen
  • 10. Lonza Group AG
  • 11. Merck KGaA
  • 12. Miltenyi Biotec
  • 13. PromoCell GmbH
  • 14. Sartorius CellGenix GmbH
  • 15. Thermo Fisher Scientific Inc.
  • 16. Vitro Diagnostics, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦